Author

Eleni Andreopoulou

Weill Cornell Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Abigail S. KingiD· 1 shared Alissa SemaaniD· 1 shared Allyson J. OceaniD· 1 shared Amanda W. LundiD· 1 shared Andrea SboneriD· 1 shared Anthony SantellaiD· 1 shared Ashley SchreieriD· 1 shared Cora Nanette SternbergiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Abigail S. KingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses

Inna S. Serganova, Giorgia Colombo, Francesco Ballesio, Jee Hye Kang, Triantafyllia R. Karakousi, Tullio Esposito, Ellen Ackerstaff, Anthony Santella, Ronald G. Blasberg, Nagavarakishore Pillarsetty, Ashley Schreier, Eleni Andreopoulou, Sandra Demaria, Amanda W. Lund, Pier Federico Gherardini, Roberta Zappasodi

This study shows that reducing tumor glycolysis improves immunotherapy responses by normalizing the tumor microenvironment and enhancing immune cell activity.

bioRxiv · Feb 24, 2026 · PreprintImmunology

Whole Genome Landscape Analysis of Homologous Recombination Deficiency in a Pan-Cancer Cohort

Majd Al Assaad, Kevin Hadi, Max Fine Levine, Daniela E. Guevara, Minal A. Patel, Marvel Tranquille, Abigail S. King, John R. Otilano, Alissa Semaan, Gunes Gundem, Juan Santiago Medina-Martinez, Michael Sigouros, Jyothi Manohar, Hui–Hsuan Kuo, David C. Wilkes, , Juan Miguel Mosquera

The paper analyzes whole-genome sequencing data from a pan-cancer cohort to define HRD, showing it extends beyond BRCA1/2 mutations and highlights the benefits of WGS over commercial assays for HRD detection.

medRxiv · Jun 28, 2024 · PreprintGenetic & Genomic Medicine